Long-term Therapeutic Success of Intravenous Rituximab in 26 Patients with Indolent Primary Cutaneous B-cell Lymphoma
Systemic monotherapy with rituximab is a well-known treatment approach for primary cutaneous follicle centre lymphoma and primary cutaneous marginal zone lymphoma. Both have excellent prognosis despite high relapse rates. To investigate the long-term effectiveness and clinical outcome of intravenous...
Saved in:
Main Authors: | Stefanie Porkert (Author), Pamela Mai (Author), Constanze Jonak (Author), Felix Weihsengruber (Author), Klemens Rappersberger (Author), Wolfgang Bauer (Author), Ingrid Simonitsch-Klupp (Author), Markus Raderer (Author), Julia Valencak (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2021-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas
by: Stefanie Porkert, et al.
Published: (2017) -
Health-related Quality of Life in Cutaneous Lymphomas: Past, Present and Future
by: Constanze Jonak, et al.
Published: (2019) -
Comparative Cost Analysis Of Intravenous And Subcutaneous Administration Of Rituximab In Lymphoma Patients
by: Delgado Sánchez O, et al.
Published: (2019) -
Effectiveness of Bendamustine-Rituximab Compared to R-CHOP/R-CVP as a First-Line Treatment of Indolent Non-Hodgkin's Lymphoma or Mantle-Cell Lymphoma
by: Brenda Cristie Edina, et al.
Published: (2022) -
Capillary Leak Syndrome From Rituximab Therapy of Lymphoma
by: Krishna Vedala MD, MPH, et al.
Published: (2020)